1-8 of 8
Guillem Argilés
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of Shared Variants between Cancer Biospecimens

Michael B. Foote, James Robert White, Walid K. Chatila, Guillem Argilés, Steve Lu, Benoit Rousseau, Oliver Artz, Paul Johannet, Henry Walch, Mitesh Patel, Michelle F. Lamendola-Essel, David Casadevall, Somer Abdelfattah, Shrey Patel, Rona Yaeger, Andrea Cercek, Clara Montagut, Michael Berger, Nikolaus Schultz, Luis A. Diaz, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2): 376–386.
https://doi.org/10.1158/1078-0432.CCR-24-1583
Published: 17 January 2025
View article titled, Analysis of Shared Variants between Cancer Biospecimens
Open the PDF for Analysis of Shared Variants between Cancer Biospecimens in another window
Includes: Supplementary data
Journal Articles

Facts and Hopes in Colorectal Cancer Immunotherapy

Michael B. Foote, Guillem Argilés, Benoit Rousseau, Neil H. Segal
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (20): 4032–4039.
https://doi.org/10.1158/1078-0432.CCR-22-2176
Published: 13 October 2023
View article titled, Facts and Hopes in Colorectal Cancer Immunotherapy
Open the PDF for Facts and Hopes in Colorectal Cancer Immunotherapy in another window
Journal Articles

Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer

Adam Lafferty, Alice C. O'Farrell, Giorgia Migliardi, Niraj Khemka, Andreas U. Lindner, Francesco Sassi, Eugenia R. Zanella, Manuela Salvucci, Evy Vanderheyden, Elodie Modave, Bram Boeckx, Luise Halang, Johannes Betge, Matthias P.A. Ebert, Patrick Dicker, Guillem Argilés, Josep Tabernero, Rodrigo Dienstmann, Enzo Medico, Diether Lambrechts, Andrea Bertotti, Claudio Isella, Livio Trusolino, Jochen H.M. Prehn, Annette T. Byrne
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (21): 5979–5992.
https://doi.org/10.1158/1078-0432.CCR-21-0818
Published: 01 November 2021
View article titled, Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer
Open the PDF for Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer

Francisco J. Sánchez-Martín, Beatriz Bellosillo, Mariona Gelabert-Baldrich, Alba Dalmases, Israel Cañadas, Joana Vidal, Alejandro Martinez, Guillem Argilés, Giulia Siravegna, Sabrina Arena, Klaus Koefoed, Laura Visa, Oriol Arpí, Ivan David Horak, Mar Iglesias, Christopher Stroh, Michael Kragh, Ana Rovira, Joan Albanell, Josep Tabernero, Alberto Bardelli, Clara Montagut
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (13): 3260–3267.
https://doi.org/10.1158/1078-0432.CCR-15-2400
Published: 30 June 2016
View article titled, The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer
Open the PDF for The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer

Oriol Arqués, Irene Chicote, Isabel Puig, Stephan P. Tenbaum, Guillem Argilés, Rodrigo Dienstmann, Natalia Fernández, Ginevra Caratù, Judit Matito, Daniel Silberschmidt, Jordi Rodon, Stefania Landolfi, Aleix Prat, Eloy Espín, Ramón Charco, Paolo Nuciforo, Ana Vivancos, Wenlin Shao, Josep Tabernero, Héctor G. Palmer
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (3): 644–656.
https://doi.org/10.1158/1078-0432.CCR-14-3081
Published: 31 January 2016
View article titled, Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer
Open the PDF for Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García, Martín A. Rivas, Yasir H. Ibrahim, María Teresa Calvo, Albert Gris-Oliver, Olga Rodríguez, Judit Grueso, Pilar Antón, Marta Guzmán, Claudia Aura, Paolo Nuciforo, Katti Jessen, Guillem Argilés, Rodrigo Dienstmann, Andrea Bertotti, Livio Trusolino, Judit Matito, Ana Vivancos, Irene Chicote, Héctor G. Palmer, Josep Tabernero, Maurizio Scaltriti, José Baselga, Violeta Serra
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (24): 5499–5510.
https://doi.org/10.1158/1078-0432.CCR-14-3091
Published: 14 December 2015
View article titled, MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by <em>TP53</em> Mutation in Preclinical Models of Colorectal Cancer
Open the PDF for MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by <em>TP53</em> Mutation in Preclinical Models of Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients with Advanced Malignancies

Shilpa Gupta, Guillem Argilés, Pamela N. Munster, Antoine Hollebecque, Olav Dajani, Jonathan D. Cheng, Ruixue Wang, Ann Swift, Alessandra Tosolini, Sarina A. Piha-Paul
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (23): 5235–5244.
https://doi.org/10.1158/1078-0432.CCR-15-0180
Published: 30 November 2015
View article titled, A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients with Advanced Malignancies
Open the PDF for A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients with Advanced Malignancies in another window
Includes: Supplementary data
Journal Articles

A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells

Isabel Puig, Irene Chicote, Stephan P. Tenbaum, Oriol Arqués, José Raúl Herance, Juan D. Gispert, José Jimenez, Stefania Landolfi, Karina Caci, Helena Allende, Leire Mendizabal, Debora Moreno, Ramón Charco, Eloy Espín, Aleix Prat, Maria Elena Elez, Guillem Argilés, Ana Vivancos, Josep Tabernero, Santiago Rojas, Héctor G. Palmer
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (24): 6787–6801.
https://doi.org/10.1158/1078-0432.CCR-12-1740
Published: 16 December 2013
View article titled, A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells
Open the PDF for A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells in another window
Includes: Supplementary data